Products
Products
Products
Sales, R&D and Manufacturing Facility 55A & 53B Fawcett Road, Coquitlam BC V3K 6V2 Canada
Amphetamine (AMP) Rapid Test
CE APPROVED
Cut off: 300 ng/ml, 500 ng/ml, 1000 ng/ml
A rapid test for the qualitative detection of Amphetamine in human urine.
For laboratory in vitro diagnostic use only.
Intended Use:
Biocan Tell Me Fast Amphetamine (AMP) Rapid Test Cassette/Strip (Urine) is a rapid chromatographic immunoassay for the detection of Amphetamine in human urine at a cut-off concentration of 1,000ng/mL This test will detect other related compounds, please refer to the Analytical Specificity table in the package insert. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Amphetamine is a Schedule II controlled substance available by prescription (Dexedrine®) and is also available on the illicit market. Amphetamines are a class of potent sympathomimetic agents with therapeutic applications. They are chemically related to the human body’s natural catecholamines: epinephrine and norepinephrine. Acute higher doses lead to enhanced stimulation of the central nervous system and induce euphoria, alertness, reduced appetite, and a sense of increased energy and power. Cardiovascular responses to Amphetamines include increased blood pressure and cardiac arrhythmias. More acute responses produce anxiety, paranoia, hallucinations, and psychotic behaviour. The effects of Amphetamines generally last 2-4 hours following use, and the drug has a half-life of 4-24 hours in the body. About 30% of Amphetamines are excreted in the urine in unchanged form, with the remainder as hydroxylated and deaminated derivatives. Biocan AMP Rapid Test Device (Urine) is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Amphetamines in urine. Biocan AMP Rapid Test (Urine) yields a positive result when Amphetamines in urine exceed 1,000 ng/mL, 500 ng/ml or 500 ng/ml.
Barbiturates (BAR) Rapid Test
CE APPROVED
Cut off: 200 ng/ml, 300 ng/ml
A rapid test for the qualitative detection of Barbiturates in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The BAR Cassette/Strip (Urine) is a lateral flow chromatographic immunoassay for the detection of Barbiturates in urine at a cut-off concentration of 300 ng/mL. This test will detect other related compounds, please refer to the Analytical Specificity table in this package insert. This assay provides only a qualitative, preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Barbiturates are central nervous system depressants. They are used therapeutically as sedatives, hypnotics, and anticonvulsants. Barbiturates are almost always taken orally as capsules or tablets. The effects resemble those of intoxication with alcohol. Chronic use of Barbiturates leads to tolerance and physical dependence. Short acting Barbiturates taken at 400 mg/day for 2-3 months produce a clinically significant degree of physical dependence. Withdrawal symptoms experienced during periods of drug abstinence can be severe enough to cause death. Only a small amount (less than 5%) of most Barbiturates are excreted unaltered in the urine. The detection period for the Barbiturates in the urine is 4-7 days. Biocan BAR Cassette/Strip (Urine) yields a positive result when Barbiturates in urine exceed 200 ng/ml or 300 ng/ml.
Benzodiazepine (BZO) Rapid Test
CE APPROVED
Cut off: 100 ng/ml, 200 ng/ml, 300 ng/ml, 500 ng/ml
A rapid test for the qualitative detection of Benzodiazepines in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The BZO Cassette/Strip (Urine) is a rapid chromatographic immunoassay for the detection of Oxazepam (major metabolite) in urine at a cut-off concentration of 300ng/ml. This test will detect other related compounds, please refer to the Analytical Specificity table in this package insert. This assay provides only a qualitative, preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Benzodiazepines are medications that are frequently prescribed for the symptomatic treatment of anxiety and sleep disorders. They produce their effects via specific receptors involving a neurochemical called gamma aminobutyric acid (GABA). Because they are safer and more effective, Benzodiazepines have replaced Barbiturates in the treatment of both anxiety and insomnia. Benzodiazepines are also used as sedatives before some surgical and medical procedures, and for the treatment of seizure disorders and alcohol withdrawal. Risk of physical dependence increases if Benzodiazepines are taken regularly (e.g., daily) for more than a few months, especially at higher than normal doses. Stopping abruptly can bring on such symptoms as trouble sleeping, gastrointestinal upset, feeling unwell, loss of appetite, sweating, trembling, weakness, anxiety and changes in perception. Only trace amounts (less than 1%) of most Benzodiazepines are excreted unaltered in the urine; most of the concentration in urine is conjugated drug. The detection period for the Benzodiazepines in the urine is 3-7 days. The BZO Cassette (Urine) is a rapid urine-screening test that can be performed without the use of an instrument. The test utilizes the antibody to selectively detect elevated levels of Benzodiazepines in urine. The BZO Cassette (Urine) yields a positive result when the Benzodiazepines in urine exceeds the 100 ng/ml, 200 ng/ml, 300 ng/ml, 500 ng/ml.
Cocaine (COC) Rapid Test
CE APPROVED
Cut off: 100 ng/ml, 150 ng/ml, 300 ng/ml
A rapid test for the qualitative detection of Cocaine metabolite in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The Cocaine (COC) Test Cassette/Strip (Urine) is a rapid chromatographic immunoassay for the qualitative detection of Cocaine metabolite, Benzoylecgonine, in human urine at a cut-off concentration of 300 ng/mL. This test will detect other related compounds, please refer to the Analytical Specificity table in this package insert. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Cocaine is a potent central nervous system (CNS) stimulant and a local anaesthetic. Initially, it brings about extreme energy and restlessness while gradually resulting in tremors, over-sensitivity and spasms. In large amounts, Cocaine causes fever, unresponsiveness, and difficulty in breathing and unconsciousness. Cocaine is often self-administered by nasal inhalation, intravenous injection and free-base smoking. It is excreted in the urine in a short time primarily as Benzoylecgonine.1,2 Benzoylecgonine, a major metabolite of Cocaine, has a longer biological half-life (5 - 8 hours) than Cocaine (0.5 - 1.5 hours), and can generally be detected for 24-48 hours after Cocaine exposure.2 The COC (Cocaine) Test Cassette is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Cocaine metabolite in urine. The COC Cassette yields a positive result when the Cocaine metabolite in urine exceeds 100 ng/ml, 150 ng/ml, 300ng/ml.
Methylenedioxymethamphetamine (MDMA) (Ecstasy) Rapid Test
CE APPROVED
Cut off: 500 ng/ml, 1000 ng/ml
A rapid test for the qualitative detection of Methylenedioxy-methamphetamine (MDMA) in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The MDMA Cassette/Strip (Urine) is a rapid chromatographic immunoassay for the detection of Methylenedioxy-methamphetamine (the primary ingredient of Ecstasy) in human urine at a cut-off concentration of 500 ng/mL. This test will detect other related compounds, please refer to the Analytical Specificity table in this package insert. This assay provides only a qualitative, preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Methylenedioxy-methamphetamine (Ecstasy) is a designer drug first synthesized in 1914 by a German drug company for the treatment of obesity.1 Those who take the drug frequently report adverse effects, such as increased muscle tension and sweating. MDMA is not clearly a stimulant, although it has, in common with amphetamine drugs, a capacity to increase blood pressure and heart rate. MDMA does produce some perceptual changes in the form of increased sensitivity to light, difficulty in focusing, and blurred vision in some users. Its mechanism of action is thought to be via release of the neurotransmitter serotonin. MDMA may also release dopamine, although the general opinion is that this is a secondary effect of the drug (Nichols and Oberlender, 1990). The most pervasive effect of MDMA, occurring in virtually all people who have taken a reasonable dose of the drug, is to produce a clenching of the jaws. The MDMA Cassette yields a positive result when Methylenedioxy-methamphetamine in urine exceeds 500 ng/mL,1000 ng/mL.
Methamphetamine (MET) Rapid Test
CE APPROVED
Cut off: 300 ng/ml, 500 ng/ml, 1000 ng/ml
A rapid test for the qualitative detection of Methamphetamine in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The Methamphetamine (MET) Test Cassette/Strip (Urine) is a rapid chromatographic immunoassay for the detection of Methamphetamine in human urine at the cut-off concentration of 300 ng/ml, 500 ng/ml, 1000ng/ml. This test will detect other compounds, please refer to Analytical Specificity table in this package insert.This assay provides only a qualitative, preliminary, analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Methamphetamine is an addictive stimulant drug that strongly activates certain systems in the brain. Methamphetamine is closely related chemically to Amphetamine, but the central nervous system effects of Methamphetamine are greater. Methamphetamine is made in illegal laboratories and has a high potential for abuse and dependence. The drug can be taken orally, injected, or inhaled. Acute higher doses lead to enhanced stimulation of the central nervous system and induce euphoria, alertness, reduced appetite, and a sense of increased energy and power. Cardiovascular responses to Methamphetamine include increased blood pressure and cardiac arrhythmias. More acute responses produce anxiety, paranoia, hallucinations, psychotic behaviour, and eventually, depression and exhaustion. The effects of Methamphetamine generally last 2-4 hours and the drug have a half-life of 9-24 hours in the body. Methamphetamine is excreted in the urine primarily as Amphetamine, and oxidized and deaminated derivatives. However, 10-20% of Methamphetamine is excreted unchanged. Thus, the presence of the parent compound in the urine indicates Methamphetamine use. Methamphetamine is generally detectable in the urine for 3-5 days, depending on urine pH level. The MET Test Cassette is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Methamphetamine in urine. The MET Test Cassette yields a positive result when the Methamphetamine in urine exceeds 300 ng/ml, 500 ng/ml, 1,000ng/mL.
Morphine (MOP) Rapid Test
CE APPROVED
Cut off: 100 ng/ml, 300 ng/ml
A rapid test for the qualitative detection of Morphine in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The Morphine (MOP) Test Cassette/Strip (Urine) is a rapid chromatographic immunoassay for the detection of Morphine in human urine at the cut-off concentration of 100 ng/ml, 300ng/ml. This test will detect other compounds, please refer to Analytical Specificity table in this package insert. This assay provides only a qualitative, preliminary, analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Opioid analgesics comprise a large group of substances which control pain by depressing the central nervous system. Large doses of Morphine can produce higher tolerance levels and physiological dependency in users and may lead to substance abuse. Morphine is excreted unmetabolized and is also the major metabolic product of codeine and heroin. Morphine is detectable in the urine for several days after an opiate dose. The MOP Test Cassette is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Morphine in urine. The MOP Test (Urine) yields a positive result when Morphine in urine reaches 100 ng/ml, 300ng/mL.
Cut off: 300 ng/ml, 2000 ng/ml
A rapid test for the qualitative detection of Morphine in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The OPI Test Cassette/Strip (Urine) is a rapid chromatographic immunoassay for the detection of Morphine in human urine at the cut-off concentration of 300 ng/ml, 2,000 ng/mL. This test will detect other related compounds, please refer to the Analytical Specificity table in this package insert. This assay provides only a qualitative, preliminary, analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Opiate refers to any drug that is derived from the opium poppy, including the natural products, Morphine and Codeine, and the semi-synthetic drugs such as heroin. Opioid is more general, referring to any drug that acts on the opioid receptor. Opioid analgesics comprise a large group of substance which control pain by depressing the central nervous system. Large doses of Morphine can produce higher tolerance levels and physiological dependency in users and may lead to substance abuse. Morphine is excreted unmetabolized and is also the major metabolic product of codeine and heroin. Morphine is detectable in the urine for several days after an opiate dose. The OPI Test (Urine) is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Morphine in urine. The OPI Test (Urine) yields a positive result when Morphine in urine exceeds 300 ng/ml, 2,000 ng/mL.
Opiates (OPI) Rapid Test
CE APPROVED
Cut off: 200 ng/ml, 300 ng/ml
A rapid test for the qualitative detection of Methadone in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The MTD Test Cassette/Strip (Urine) is a lateral flow chromatographic immunoassay for the detection of Methadone in human urine at a cut-off concentration of 200 ng/ml, 300ng/ml. This test will detect other related compounds, please refer to the Analytical Specificity table in this package insert. This assay provides only a qualitative, preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Methadone is a narcotic pain reliever for medium to severe pain. It is also used in the treatment of Heroin (Opiate dependence: Vicodin, Percolate, Morphine, etc) addiction. Oral Methadone is very different than the IV Methadone. Oral Methadone is partially stored in the liver for later use. IV Methadone acts more like Heroin. Methadone is a long acting pain reliever producing effects that last between twelve to forty-eight hours. Ideally, Methadone frees the client from the pressures of obtaining illegal Heroin, from the dangers of injection, and from the emotional roller coaster that most Opiates produce. Methadone, if taken for long periods and at large doses, can lead to a very long withdrawal period. The withdrawals from Methadone are more prolonged and troublesome than those provoked by heroin cessation, yet the substitution and phased removal of methadone is an acceptable method of detoxification for patients and therapists. The MTD Test (Urine) is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Methadone in urine. The MTD Test (Urine) yields a positive result when the Methadone in urine exceeds 200 ng/ml, 300 ng/mL.
Methadone (MTD) Rapid Test
CE APPROVED
Cut off: 1000 ng/ml
A rapid test for the qualitative detection of Tricyclic Antidepressants in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The TCA Test Cassette/Strip (Urine) is a lateral flow chromatographic immunoassay for the detection of Nortriptyline in human urine at a cut-off concentration of 1,000 ng/mL. This test will detect other related compounds, please refer to the Analytical Specificity table in this package insert. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) or high performance liquid chromatography (HPLC) are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
TCA (Tricyclic Antidepressants) are commonly used for the treatment of depressive disorders. TCA overdoses can result in profound central nervous system depression, cardiotoxicity and anticholinergic effects. TCA overdose is the most common cause of death from prescription drugs. TCAs are taken orally and sometimes by injection. TCAs are metabolized in the liver, both TCAs and their metabolites are excreted in urine mostly in the form of metabolites for up to ten days. The TCA Test (Urine) is a rapid urine-screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Nortriptyline in urine. The TCA Test (Urine) yields a positive result when the Nortriptyline in urine exceeds 1,000 ng/mL.
Tricyclic Antidepressants (TCA) Rapid Test
CE APPROVED
Cut off: 20ng/ml, 25 ng/ml, 50 ng/ml, 150 ng/ml, 300 ng/ml, 600 ng/ml
A rapid test for the qualitative detection of Marijuana in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The THC Test Cassette/Strip (Urine) is a rapid chromatographic immunoassay for the detection of 11-nor-D9 -THC-9 COOH (THC metabolite) in human urine at a cut-off concentration of 20ng/ml, 25 ng/ml, 50 ng/ml, 150 ng/ml, 300 ng/ml, 600 ng/ml.This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrophotometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
THC (D9-tetrahydrocannabinol) is the primary active ingredient in cannabinoids (Marijuana). When smoked or orally administered, it produces euphoric effects. Users have impaired short term memory and slowed learning. Users may also experience transient episodes of confusion and anxiety. Long term relatively heavy use may be associated with behavioral disorders. The peak effect of smoking Marijuana occurs in 20-30 minutes and the duration is 90-120 minutes after one cigarette. Elevated levels of urinary metabolites are found within hours of exposure and remain detectable for 3-10 days after smoking. The main metabolite excreted in the urine is 11-nor-D9-tetrahydrocannabinol-9-carboxylic acid (D9-THC-COOH). The THC Test (Urine) is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Marijuana in urine. The THC Test yields a positive result when the concentration of Marijuana in urine exceeds 20ng/ml, 25 ng/ml, 50 ng/ml, 150 ng/ml, 300 ng/ml, 600 ng/ml.
Tetrahydrocannabinol (THC) Rapid Test
CE APPROVED
Cut off: 5 ng/ml, 10 ng/ml
A rapid test for the qualitative detection of Buprenorphine in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The BUP Test Cassette/Strip (Urine) is a rapid chromatographic immunoassay for the detection of Buprenorphine in human urine at a cut-off concentration of 5 ng/ml, 10 ng/ml. This test will detect other related compounds, please refer to the Analytical Specificity table in this package insert. This assay provides only a qualitative, preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) or Liquid Chromatography/mass spectrometry (LC/MS) are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Buprenorphine is a potent analgesic often used in the treatment of opioid addiction. The drug is sold under the trade names Subutex,™ Buprenex,™ Temgesic,™ and Suboxone™ which contain Buprenorphine HCl alone or in combination with Naloxone HCl. Therapeutically, Buprenorphine is used as a substitution treatment for opioid addicts. Substitution treatment is a form of medical care offered to opiate addicts (primarily heroin addicts) based on a similar or identical substance to the drug normally used. In substitution therapy, Buprenorphine is as effective as Methadone but demonstrates a lower level of physical dependence. Concentrations of free Buprenorphine and Norbuprenorphine in urine may be less than 1 ng/mL after therapeutic administration, but can range up to 20 ng/mL in abuse situations. The plasma half-life of Buprenorphine is 2-4 hours.1 while complete elimination of a single-dose of the drug can take as long as 6 days, the detection window for the parent drug in urine is thought to be approximately 3 days.The BUP Test (Urine) is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Buprenorphine in urine. The BUP Test (Urine) yields a positive result when Buprenorphine in urine exceeds 5 ng/ml, 10 ng/ml.
Buprenorphine (BUP) Rapid Test
CE APPROVED
Cut off: 100 ng/ml
A rapid test for the qualitative detection of Oxycodone in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The OXY Test Cassette/Strip (Urine) is a rapid chromatographic immunoassay for the detection of Oxycodone in human urine at a cut-off concentration of 100 ng/mL. This test will detect other related compounds, please refer to Analytical Specificity table in this package insert. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Oxycodone is a semi-synthetic opioid with a structural similarity to codeine. The drug is manufactured by modifying thebaine, an alkaloid found in the opium poppy. Oxycodone, like all opiate agonists, provides pain relief by acting on opioid receptors in the spinal cord, brain, and possibly directly in the affected tissues. Oxycodone is prescribed for the relief of moderate to high pain under the well-known pharmaceutical trade names of OxyContin®, Tylox®, Percodan® and Percocet®. While Tylox®, Percodan® and Percocet® contain only small doses of oxycodone hydrochloride combined with other analgesics such as acetaminophen or aspirin, OxyContin consists solely of oxycodone hydrochloride in a time-release form. Oxycodone is known to metabolize by demethylation into oxymorphone and noroxycodone. In a 24-hour urine, 33-61% of a single, 5 mg oral dose is excreted with the primary constituents being unchanged drug (13-19%), conjugated drug (7-29%) and conjugated oxymorphone (13-14%).1 The window of detection for Oxycodone in urine is expected to be similar to that of other opioids such as morphine.The OXY Test (Urine) is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Oxycodone in urine. The OXY Test (Urine) yields a positive result when the Oxycodone level in urine exceeds 100 ng/mL.
Oxycodone (OXY) Rapid Test
CE APPROVED
Cut off: 25 ng/ml
A rapid test for the qualitative detection of Phencyclidine in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The PCP Test Cassette/Strip (Urine) is a rapid chromatographic immunoassay for the detection of Phencyclidine in urine at a cut-off concentration of 25 ng/mL. This test will detect other related compounds, please refer to the Analytical Specificity table in this package insert.This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Phencyclidine, also known as PCP, is a hallucinogen that was first marketed as a surgical anesthetic in the 1950’s. It was removed from the market because patients receiving it became delirious and experienced hallucinations. Phencyclidine is used in powder, capsule, and tablet form. The powder is either snorted or smoked after mixing it with marijuana or vegetable matter. PCP is most commonly administered by inhalation but can be used intravenously, intra-nasally, and orally. After low doses, the user thinks and acts swiftly and experiences mood swings from euphoria to depression. Self-injurious behavior is one of the devastating effects of PCP.PCP can be found in urine within 4 to 6 hours after use and will remain in urine for 7 to 14 days, depending on factors such as metabolic rate, user’s age, weight, activity, and diet. PCP is excreted in the urine as unchanged drug (4% to 19%) and conjugated metabolites (25% to 30%). The PCP Test (Urine) yields a positive result when the PCP level in urine exceeds 25 ng/mL.
Phencyclidine (PCP) Rapid Test
CE APPROVED
Cut off: 100 ng/ml, 300 ng/ml
A rapid test for the qualitative detection of Tramadol in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The TML Test Cassette/Strip (Urine) is a rapid immunochromatographic assay for the qualitative detection of Tramadol in human urine at a cut-off concentration of 100 ng/ml, 300 ng/ml. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Tramadol (TML) is a quasi-narcotic analgesic used in the treatment of moderate to severe pain. It is a synthetic analog of codeine, but has a low binding affinity to the mu-opioid receptors. Large doses of tramadol can develop tolerance and physiological dependency and lead to its abuse. Tramadol is extensively metabolized after oral administration. Approximately 30% of the dose is excreted in the urine as unchanged drug, whereas 60% is excreted as metabolites. The major pathways appear to be N- and O- demethylation, glucoronidation or sulfation in the liver. The TML Test (Urine) is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Tramadol in urine. The TML Test (Urine) yields a positive result when Tramadol in urine exceed 100 ng/ml, 300 ng/ml.
Tramadol (TML) Rapid Test
CE APPROVED
Cut off: 100 ng/ml, 300 ng/ml, 500 ng/ml, 1000 ng/ml
A rapid test for the qualitative detection of Ketamine in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The KET Test Cassette/Strip (Urine) is a rapid chromatographic immunoassay for the detection of Ketamine in human urine at a cut-off concentration of 100 ng/ml, 300 ng/ml, 500 ng/ml, 1000 ng/ml. This test will detect other related compounds, please refer to the Analytical Specificity table in this package insert. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Ketamine is a dissociative anaesthetic developed in 1963 to replace PCP (Phencyclidine). While Ketamine is still used in human anaesthesia and veterinary medicine, it is becoming increasingly abused as a street drug. Ketamine is molecularly similar to PCP and thus creates similar effects including numbness, loss of coordination, sense of invulnerability, muscle rigidity, aggressive/violent behavior, slurred or blocked speech, exaggerated sense of strength, and a blank stare. There is depression of respiratory function but not of the central nervous system, and cardiovascular function is maintained. The effects of Ketamine generally last 4-6 hours following use. Ketamine is excreted in the urine as unchanged drug (2.3%) and metabolites (96.8%). The KET Test Cassette (Urine) is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Ketamine in urine. The KET Test (Urine) yields a positive result when Ketamine in urine exceeds 100 ng/ml, 300 ng/ml, 500 ng/ml, 1000 ng/ml.
Ketamine (KET) Rapid Test
CE APPROVED
Cut off: 10ng/ml, 50ng/ml, 100ng/ml, 200 ng/ml
A rapid test for the qualitative detection of Cotinine (nicotine metabolite) in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The COT Test Cassette/Strip (Urine) is a rapid chromatographic immunoassay for the detection of Cotinine in human urine at a cut-off concentration of 10ng/ml, 50ng/ml, 100ng/ml, 200 ng/ml. This test will detect other related compounds, please refer to the Analytical Specificity table in this package insert. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography and mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Cotinine is the first-stage metabolite of nicotine, a toxic alkaloid that produces stimulation of the autonomic ganglia and central nervous system when in humans. Nicotine is a drug to which virtually every member of a tobacco-smoking society is exposed whether through direct contact or second-hand inhalation. In addition to tobacco, nicotine is also commercially available as the active ingredient in smoking replacement therapies such as nicotine gum, transdermal patches and nasal sprays. In a 24-hour urine, approximately 5% of a nicotine dose is excreted as unchanged drug with 10% as cotinine and 35% as hydroxycotinine; the concentrations of other metabolites are believed to account for less than 5%.1 While cotinine is thought to be an inactive metabolite, it’s elimination profile is more stable than that of nicotine which is largely urine pH dependent. As a result, cotinine is considered a good biological marker for determining nicotine use. The plasma half-life of nicotine is approximately 60 minutes following inhalation or parenteral administration.2 Nicotine and cotinine are rapidly eliminated by the kidney; the window of detection for cotinine in urine at a cutoff level of 200 ng/mL is expected to be up to 2-3 days after nicotine use. The COT Test (Urine) is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Cotinine in urine. The COT Test (Urine) yields a positive result when the Cotinine in urine exceeds 10ng/ml, 50ng/ml, 100ng/ml, 200 ng/ml.
Cotinine (COT) Rapid Test
CE APPROVED
Cut off: 25ng/ml, 30ng/ml, 50 ng/ml
A rapid test for the qualitative detection of synthetic marijuana in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The Synthetic Cannabis (K2) Test Cassette/Strip (Urine) is a rapid chromatographic immunoassay for the detection of Synthetic Marijuana metabolite in human urine. The synthetic marijuana detected by the test includes, but are not limited to, the metabolites of JWH-018 and JWH-073. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Synthetic Cannabis or K2 is a psychoactive herbal and chemical product that, when consumed, mimics the effects of Marijuana. It is best known by the brand names K2 and Spice, both of which have largely become genericized trademarks used to refer to any synthetic Marijuana product. The studies suggest that synthetic marijuana intoxication is associated with acute psychosis, worsening of previously stable psychotic disorders, and also may have the ability to trigger a chronic (long-term) psychotic disorder among vulnerable individuals such as those with a family history of mental illness. Elevated levels of urinary metabolites are found within hours of exposure and remain detectable for 72 hours after smoking (depending on usage/dosage). As of March 1, 2011, five cannabinoids, JWH-018, JWH-073, CP-47, JWH-200 and cannabicyclo hexanol are now illegal in the US because these substances have the potential to be extremely harmful and, therefore, pose an imminent hazard to the public safety. The Synthetic Marijuana Rapid Test Cassette (Urine) is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of synthetic marijuana metabolite in human urine. The Synthetic Marijuana Rapid Test (Urine) yields a positive result when the synthetic marijuana metabolite in urine exceeds 25ng/ml, 30ng/ml, 50 ng/ml.
Synthetic Cannabis (K2) Rapid Test
CE APPROVED
Cut off: 10ng/ml, 20 ng/ml
A rapid test for the qualitative detection of FYL in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The FYL (Fentanyl) Test Cassette/Strip (Urine) is a rapid immunochromatographic assay for the qualitative detection of Norfentanyl, a metabolite of Fentanyl. It is a potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Norfentanyl is also used as adjunct to general anaesthetics, and as an anaesthetic for induction and maintenance. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Fentanyl belongs to powerful narcotics analgesics, and is a μ special opiates receptor stimulant. Fentanyl is one of the varieties that been listed in management of United Nations “Single Convention of narcotic drug in 1961”. Among the opiates agents that under international control, fentanyl is one of the most commonly used to cure moderate to severe pain. After continuous injection of fentanyl, the sufferer will have the performance of protracted opioid abstinence syndrome, such as ataxia and irritability etc, which presents the addiction after taking fentanyl in a long time. Compared with drug addicts of amphetamine, drug addicts who take fentanyl mainly have got the possibility of higher infection rate of HIV, more dangerous injection behavior and more lifelong medication overdose. The FYL Test (Urine) is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Norfentanyl in urine. The FYL Test (Urine) yields a positive result when Norfentanyl in urine exceeds 10ng/ml, 20 ng/ml.
Warning:
This test is not designed to test drugs before they are consumed.When used in this way, this test may not detect certain drugs, including Fentanyl, even if present.
Fentanyl (FYL) Rapid Test
CE APPROVED
Cut off: 300 ng/ml
A rapid test for the qualitative detection of Methaqualone in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The MQL Test Cassette/Strip (Urine) is a rapid chromatographic immunoassay for the qualitative detection of Methaqualone in human urine at a cut-off concentration of 300 ng/mL. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Methaqualone (Quaalude, Sopor) is a quinazoline derivative that was first synthesized in 1951 and found clinically effective as a sedative and hypnotic in 1956.2 It soon gained popularity as a drug of abuse and in 1984 was removed from the US market due to extensive misuse. It is occasionally encountered in illicit form, and is also available in European countries in combination with diphenhydramine (Mandrax). Methaqualone is extensively metabolized in vivo principally by hydroxylation at every possible position on the molecule. At least 12 metabolites have been identified in the urine. The MQL Test (Urine) is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Methaqualone in urine. The MQL Test (Urine) yields a positive result when Methaqualone in urine exceed 300 ng/mL.
Methaqualone (MQL) Rapid Test
CE APPROVED
Cut off: 300 ng/ml
A rapid test for the qualitative detection of Propoxyphene in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The PPX Test Cassette/Strip (Urine) is a rapid chromatographic immunoassay for the qualitative detection of Propoxyphene in human urine at a cut-off concentration of 300 ng/mL. For laboratory in vitro diagnostic use only. This test will detect other related compounds, please refer to the Analytical Specificity table in this package insert. This assay provides only a qualitative, preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Propoxyphene (PPX) is a narcotic analgesic compound bearing structural similarity to methadone. As an analgesic, Propoxyphene can be from 50-75% as potent as oral codeine. Darvocet™, one of the most common brand names for the drug, contains 50-100 mg of Propoxyphene napsylate and 325-650 mg of acetaminophen. Peak plasma concentrations of Propoxyphene are achieved from 1 to 2 hours post dose. In the case of overdose, Propoxyphene blood concentrations can reach significantly higher levels. In humans, Propoxyphene is metabolized by N-demethylation to yield Norpropoxyphene. Norpropoxyphene has a longer half-life (30 to 36 hours) than parent Propoxyphene (6 to 12 hours). The accumulation of Norpropoxyphene seen with repeated doses may be largely responsible for resultant toxicity. The PPX Test (Urine) is a rapid urine-screening test that can be performed without the use of an instrument. The test utilizes the antibody to selectively detect elevated levels of Propoxyphene in urine. The PPX Test (Urine) yields a positive result when Propoxyphene in urine exceeds 300 ng/mL.
Propoxyphene (PPX) Rapid Test
CE APPROVED
Ethylenediamine-dimethylphosphinic acid (EDDP) Rapid Test
CE APPROVED
Cut off: 100 ng/ml, 300 ng/ml
A rapid test for the qualitative detection of EDDP in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The EDDP (Methadone Metabolite) Test Cassette/Strip (Urine) is a rapid immunochromatographic assay for the qualitative detection of 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), an inactive metabolite of methadone that acts as a narcotic pain reliever and is used as a treatment for opiate addiction. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Methadone is an unusual drug in that its primary urinary metabolites (EDDP and EMDP) are cyclic in structure, making them very difficult to detect using immunoassays targeted to the native compound. Exacerbating this problem, there is a subsection of the population classified as “extensive metabolizers” of methadone. In these individuals, a urine specimen may not contain enough parent methadone to yield a positive drug screen even if the individual is in compliance with their methadone maintenance. EDDP represents a better urine marker for methadone maintenance than unmetabolized methadone. The EDDP Test (Urine) is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of EDDP in urine. The EDDP Test (Urine) yields a positive result when EDDP in urine exceeds 100 ng/ml, 300 ng/mL.
Lysergic Acid Diethylamide (LSD) Rapid Test
CE APPROVED
Cut off: 20 ng/ml
A rapid test for the qualitative detection of Lysergic Acid Diethylamide in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The Lysergic Acid Diethylamide (LSD) Test Cassette/Strip Format (Urine) is a rapid chromatographic immunoassay for the detection of Lysergic Acid Diethylamide in human urine at a cut-off concentration of 20 ng/mL. This assay provides only a qualitative, preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) or Liquid Chromatography/mass spectrometry (LC/MS) are the preferred confirmatory methods. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Lysergic acid diethylamide (LSD) is a white powder or a clear, colorless liquid. LSD is manufactured from lysergic acid which occurs naturally in the ergot fungus that grows on wheat and rye. It is a Schedule I controlled substance, available in liquid, powder, tablet (microdots), and capsule form. LSD is recreationally used as a hallucinogen for its ability to alter human perception and mood. LSD is primarily used by oral administration, but can be inhaled, injected, and transdermally applied. LSD is a non-selective 5-HT agonist, may exert its hallucinogenic effect by interacting with 5-HT 2Areceptors as a partial agonist and modulating the NMDA receptor-mediated sensory, perceptual, affective and cognitive processes. LSD mimics 5-HT at 5-HT 1A receptors, producing a marked slowing of the firing rate of serotonergic neurons. LSD has a plasma half-life of 2.5-4 hours. Metabolites of LSD include N-desmethyl-LSD, hydroxy-LSD, 2-oxo-LSD, and 2-oxo-3-hydroxy-LSD. These metabolites are all inactive. LSD use can typically be detected in urine for periods of 2-5 days. The LSD Test (Urine) is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Lysergic Acid Diethylamide in urine. The LSD Test (Urine) yields a positive result when Lysergic Acid Diethylamide in urine exceeds 20 ng/mL.
6-Monoacetylmorphine (6-MAM) Rapid Test
CE APPROVED
Cut off: 10 ng/ml
A rapid test for the qualitative detection of 6-mono-aceto-Morphine in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The 6-mono-aceto-morphine (6-MAM) Test Cassette/Strip Format (Urine) is a rapid chromatographic immunoassay for the detection of 6-mono-aceto-morphine in human urine at the cut-off concentration of 10ng/ml. This test will detect other compounds, please refer to Analytical Specificity table in this package insert. This assay provides only a qualitative, preliminary, analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
6-Monoacetylmorphine (6-MAM) or 6-acetylmorphine (6-AM) is one of three active metabolites of heroin (diacetylmorphine), the others being morphine and the much less active 3-monoacetylmorphine (3-MAM). 6-MAM is rapidly created from heroin in the body, and then is either metabolized into morphine or excreted in the urine. 6-MAM remains in the urine for no more than 24 hours. So a urine specimen must be collected soon after the last heroin use, but the presence of 6-MAM guarantees that heroin was in fact used as recently as within the last day. 6-MAM is naturally found in the brain, but in such small quantities, that detection of this compound in urine virtually guarantees that heroin has recently been consumed. The 6-MAM Test (Urine) is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of 6-MAM in urine. The 6-MAM Test (Urine) yields a positive result when Morphine in urine reaches 10ng/mL.
Zolpidem (ZOL) Rapid Test
CE APPROVED
Cut off: 50 ng/ml
A rapid test for the qualitative detection of Zolpidem in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The Zolpidem (ZOL) Test Cassette/Strip Format (Urine) is a rapid chromatographic immunoassay for the detection of Zolpidem in human urine at the cut-off concentration of 50ng/ml. Please refer to Analytical Specificity table in this package insert for details on reactivity.This assay provides only a qualitative, preliminary, analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Zolpidem (brand names Ambien, Ambien CR, Intermezzo, Stilnox, Stilnoct, Sublinox, Hypnogen, Zonadin, Sanval and Zolsana) is a prescription medication used for the treatment of insomnia and some brain disorders. It is a short-acting nonbenzodiazepine hypnotic of the imidazopyridine class that potentiates GABA, an inhibitory neurotransmitter, by binding to GABAA receptors at the same location as benzodiazepines.It works quickly, usually within 15 minutes, and has a short half-life of two to three hours. Zolpidem may be detected in blood or plasma to confirm a diagnosis of poisoning in hospitalized patients, provide evidence in an impaired driving arrest, or to assist in a medico-legal death investigation. Blood or plasma Zolpidem concentrations are usually in a range of 30–300 μg/l in persons receiving the drug therapeutically, 100–700 μg/l in those arrested for impaired driving, and 1000–7000 μg/l in victims of acute overdosage. Analytical techniques, in general, involve gas or liquid chromatography. The ZOL Test (Urine) is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes monoclonal antibodies to selectively detect elevated levels of Zolpidem in urine. The ZOL Test (Urine) yields a positive result when Zolpidem in urine reaches 50ng/ml.
Ethyl Glucuronide (ETG) Rapid Test
CE APPROVED
Cut off: 500 ng/ml, 1000 ng/ml
A rapid test for the qualitative detection of Ethyl Glucuronide in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The Ethyl Glucuronide (ETG) Test Cassette/Strip Format (Urine) is a rapid chromatographic immunoassay for the detection of Ethyl Glucuronide in human urine at cutoff of 500ng/mL. The Ethyl Glucuronide detected by the test includes, but are not limited to, the metabolites of Ethanol.This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Ethyl Glucuronide (ETG) is a metabolite of ethyl alcohol which is formed in the body by glucuronidation following exposure to ethanol, such as by drinking alcoholic beverages. It is used as a biomarker to test for ethanol use and to monitor alcohol abstinence in situations where drinking is prohibited, such as in the military, in professional monitoring programs (health professionals, attorneys, airline pilots in recovery from addictions), in schools, in liver transplant clinics, or in recovering alcoholic patients. ETG can be measured in urine up to approximately 80 hours after ethanol is ingested. ETG is a more accurate indicator of the recent exposure to alcohol than measuring for the presence of ethanol itself. The Ethyl Glucuronide Test (Urine) is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of ethyl glucuronide in human urine. The Ethyl Glucuronide Test (Urine) yields a positive result when the Ethyl Glucuronide in urine exceeds 500 ng/ml, 1000 ng/ml.
Cathinon (CAT) Rapid Test
CE APPROVED
Cut off: 150 ng/ml
A rapid test for the qualitative detection of Cathine in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The CAT Test Cassette/Strip Format (Urine) is a rapid chromatographic immunoassay for the detection of Cathine in urine at a cut-off concentration of 150ng/ml. This test will detect other related compounds, please refer to the Analytical Specificity table in this package insert.This assay provides only a qualitative, preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
Summary:
Cathinone, also known as benzoylethanamine, or β-keto-amphetamine is a monoamine alkaloid found in the shrub Catha edulis (CAT) and is chemically similar to ephedrine, Cathinone, methCathinone and other amphetamines. It with amphetamine, ephedrine, methamphetamine and mephedrone belongs to excitatory amphetamines psychiatric drugs, has the strong central excitement and suppress appetite, has been widely applied in the depression, fatigue, obesity, gastric ulcer, etc. The earliest found in Arab tea, because of its structure and pharmacological activities are similar to amphetamines, so called "natural amphetamine. It has approximately 10-14% the potency of amphetamine. S-(-)-Cathinone (S-(-)-alpha-aminopropiophenone) is the major active principle of khat leaves (Catha edulis), which are widely used in East Africa and the Arab peninsula as an amphetamine-like stimulant. After oral administration of synthesized cathinone (isomers, racemate), 22-52% was recovered in 24 h urine samples mainly as aminoalcohol metabolites. With GC/MS, HPLC and CD, the main metabolite of S-(-)-cathinone was identified as R/S-(-)-norephedrine and the main metabolite of R-(+)-cathinone as R/R-(-)-norpseudoephedrine. Both aminoalcohols are formed by a stereospecific keto reduction. Use too much Cathinone can cause loss of appetite, anxiety, irritability, insomnia, illusion and panic attacks. Abusers have for a long time for the development of personality disorder and continuing the risk of myocardial infarction. The World Anti-Doping Agency's list of prohibited substances (used for the Olympic Games among other athletic events) bars cathine in concentrations of over 5 micrograms per milliliter in urine. Cathine is a Schedule III drug under the Convention on Psychotropic Substances.
Multi 16 Drug Rapid Test
CE APPROVED
Cut off: 50 ng/ml
A rapid test for the qualitative detection of multiple drugs and drug metabolites in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The Multi-Drug Test Dip card Panel is a rapid chromatographic immunoassay for the qualitative detection of multiple drugs and drug metabolites in urine at the following cut-off concentrations:
Test
Amphetamine (AMP1,000)
Amphetamine (AMP 500)
Amphetamine (AMP 300)
Barbiturates (BAR 300)
Barbiturates (BAR 200)
Benzodiazepines (BZO 500)
Benzodiazepines (BZO 300)
Benzodiazepines (BZO 200)
Benzodiazepines (BZO 100)
Buprenorphine (BUP)
Cocaine (COC 300)
Cocaine (COC 100)
Marijuana (THC150)
Marijuana (THC 50)
Marijuana (THC 25)
Methadone (MTD 300)
Methadone (MTD 200)
Methamphetamine (MET 1,000)
Methamphetamine (MET 500)
Methamphetamine (MET 300)
Methylenedioxymethamphetamine (MDMA 500)
Methylenedioxymethamphetamine (MDMA 1,000)
Morphine (MOP 300)
Morphine (MOP 100)
Methaqualone(MQL)
Opiate (OPI 2,000)
Phencyclidine (PCP)
Propoxyphene (PPX)
Tricyclic Antidepressants (TCA)
Tramadol (TML)
Ketamine (KET 1,000)
Ketamine (KET 500)
Ketamine (KET 300)
Ketamine (KET 100)
Oxycodone (OXY)
Cotinine(COT200)
Cotinine(COT100)
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP300)
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP100)
Fentanyl (FYL20)
Fentanyl (FYL10)
Synthetic Marijuana (K2-50)
Synthetic Marijuana (K2-30)
6-mono-aceto-morphine (6-MAM10)
(±) 3,4-Methylenedioxy- Amphetamine(MDA500)
Calibrator
Cut-off (ng/mL)
d-Amphetamine
d-Amphetamine
d-Amphetamine
Secobarbital
Secobarbital
Oxazepam
Oxazepam
Oxazepam
Oxazepam
Buprenorphine
Benzoylecgonine
Benzoylecgonine
11-nor-Δ9-THC-9 COOH
11-nor-Δ9-THC-9 COOH
11-nor-Δ9-THC-9 COOH
Methadone
Methadone
d-Methamphetamine
d-Methamphetamine
d-Methamphetamine
d,l-Methylenedioxymethamphetamine
d,l-Methylenedioxymethamphetamine
Morphine
Morphine
Methaqualone
Morphine
Phencyclidine
Propoxyphene
Nortriptyline
Cis-Tramadol
Ketamine
Ketamine
Ketamine
Ketamine
Oxycodone
Cotinine
Cotinine
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine
Norfentanyl
Norfentanyl
JWH-018、JWH-073
JWH-018、JWH-073
6-MAM
(±) 3,4-Methylenedioxy- Amphetamine
1000
500
300
300
200
500
300
200
100
10
300
100
150
50
25
300
200
1000
500
300
500
1000
300
100
300
2000
25
300
1000
100
1000
500
300
100
100
200
100
300
100
20
10
50
30
10
500
Configurations of The Multi-Drug Test Cassette come with any combination of the above listed drug analytes. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.
Multi 15 Drug Rapid Test
CE APPROVED
Cut off: 50 ng/ml
A rapid test for the qualitative detection of multiple drugs and drug metabolites in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The Multi-Drug Test Dip card Panel is a rapid chromatographic immunoassay for the qualitative detection of multiple drugs and drug metabolites in urine at the following cut-off concentrations:
Test
Amphetamine (AMP1,000)
Amphetamine (AMP 500)
Amphetamine (AMP 300)
Barbiturates (BAR 300)
Barbiturates (BAR 200)
Benzodiazepines (BZO 500)
Benzodiazepines (BZO 300)
Benzodiazepines (BZO 200)
Benzodiazepines (BZO 100)
Buprenorphine (BUP)
Cocaine (COC 300)
Cocaine (COC 100)
Marijuana (THC150)
Marijuana (THC 50)
Marijuana (THC 25)
Methadone (MTD 300)
Methadone (MTD 200)
Methamphetamine (MET 1,000)
Methamphetamine (MET 500)
Methamphetamine (MET 300)
Methylenedioxymethamphetamine (MDMA 500)
Methylenedioxymethamphetamine (MDMA 1,000)
Morphine (MOP 300)
Morphine (MOP 100)
Methaqualone(MQL)
Opiate (OPI 2,000)
Phencyclidine (PCP)
Propoxyphene (PPX)
Tricyclic Antidepressants (TCA)
Tramadol (TML)
Ketamine (KET 1,000)
Ketamine (KET 500)
Ketamine (KET 300)
Ketamine (KET 100)
Oxycodone (OXY)
Cotinine(COT200)
Cotinine(COT100)
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP300)
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP100)
Fentanyl (FYL20)
Fentanyl (FYL10)
Synthetic Marijuana (K2-50)
Synthetic Marijuana (K2-30)
6-mono-aceto-morphine (6-MAM10)
(±) 3,4-Methylenedioxy- Amphetamine(MDA500)
Calibrator
Cut-off (ng/mL)
d-Amphetamine
d-Amphetamine
d-Amphetamine
Secobarbital
Secobarbital
Oxazepam
Oxazepam
Oxazepam
Oxazepam
Buprenorphine
Benzoylecgonine
Benzoylecgonine
11-nor-Δ9-THC-9 COOH
11-nor-Δ9-THC-9 COOH
11-nor-Δ9-THC-9 COOH
Methadone
Methadone
d-Methamphetamine
d-Methamphetamine
d-Methamphetamine
d,l-Methylenedioxymethamphetamine
d,l-Methylenedioxymethamphetamine
Morphine
Morphine
Methaqualone
Morphine
Phencyclidine
Propoxyphene
Nortriptyline
Cis-Tramadol
Ketamine
Ketamine
Ketamine
Ketamine
Oxycodone
Cotinine
Cotinine
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine
Norfentanyl
Norfentanyl
JWH-018、JWH-073
JWH-018、JWH-073
6-MAM
(±) 3,4-Methylenedioxy- Amphetamine
1000
500
300
300
200
500
300
200
100
10
300
100
150
50
25
300
200
1000
500
300
500
1000
300
100
300
2000
25
300
1000
100
1000
500
300
100
100
200
100
300
100
20
10
50
30
10
500
Configurations of The Multi-Drug Test Cassette come with any combination of the above listed drug analytes. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.
Multi 14 Drug Rapid Test
CE APPROVED
Cut off: 50 ng/ml
A rapid test for the qualitative detection of multiple drugs and drug metabolites in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The Multi-Drug Test Dip card Panel is a rapid chromatographic immunoassay for the qualitative detection of multiple drugs and drug metabolites in urine at the following cut-off concentrations:
Test
Amphetamine (AMP1,000)
Amphetamine (AMP 500)
Amphetamine (AMP 300)
Barbiturates (BAR 300)
Barbiturates (BAR 200)
Benzodiazepines (BZO 500)
Benzodiazepines (BZO 300)
Benzodiazepines (BZO 200)
Benzodiazepines (BZO 100)
Buprenorphine (BUP)
Cocaine (COC 300)
Cocaine (COC 100)
Marijuana (THC150)
Marijuana (THC 50)
Marijuana (THC 25)
Methadone (MTD 300)
Methadone (MTD 200)
Methamphetamine (MET 1,000)
Methamphetamine (MET 500)
Methamphetamine (MET 300)
Methylenedioxymethamphetamine (MDMA 500)
Methylenedioxymethamphetamine (MDMA 1,000)
Morphine (MOP 300)
Morphine (MOP 100)
Methaqualone(MQL)
Opiate (OPI 2,000)
Phencyclidine (PCP)
Propoxyphene (PPX)
Tricyclic Antidepressants (TCA)
Tramadol (TML)
Ketamine (KET 1,000)
Ketamine (KET 500)
Ketamine (KET 300)
Ketamine (KET 100)
Oxycodone (OXY)
Cotinine(COT200)
Cotinine(COT100)
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP300)
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP100)
Fentanyl (FYL20)
Fentanyl (FYL10)
Synthetic Marijuana (K2-50)
Synthetic Marijuana (K2-30)
6-mono-aceto-morphine (6-MAM10)
(±) 3,4-Methylenedioxy- Amphetamine(MDA500)
Calibrator
Cut-off (ng/mL)
d-Amphetamine
d-Amphetamine
d-Amphetamine
Secobarbital
Secobarbital
Oxazepam
Oxazepam
Oxazepam
Oxazepam
Buprenorphine
Benzoylecgonine
Benzoylecgonine
11-nor-Δ9-THC-9 COOH
11-nor-Δ9-THC-9 COOH
11-nor-Δ9-THC-9 COOH
Methadone
Methadone
d-Methamphetamine
d-Methamphetamine
d-Methamphetamine
d,l-Methylenedioxymethamphetamine
d,l-Methylenedioxymethamphetamine
Morphine
Morphine
Methaqualone
Morphine
Phencyclidine
Propoxyphene
Nortriptyline
Cis-Tramadol
Ketamine
Ketamine
Ketamine
Ketamine
Oxycodone
Cotinine
Cotinine
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine
Norfentanyl
Norfentanyl
JWH-018、JWH-073
JWH-018、JWH-073
6-MAM
(±) 3,4-Methylenedioxy- Amphetamine
1000
500
300
300
200
500
300
200
100
10
300
100
150
50
25
300
200
1000
500
300
500
1000
300
100
300
2000
25
300
1000
100
1000
500
300
100
100
200
100
300
100
20
10
50
30
10
500
Configurations of The Multi-Drug Test Cassette come with any combination of the above listed drug analytes. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.
Multi 12 Drug Rapid Test
CE APPROVED
Cut off: 50 ng/ml
A rapid test for the qualitative detection of multiple drugs and drug metabolites in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The Multi-Drug Test Cassette/Dip card Panel is a rapid chromatographic immunoassay for the qualitative detection of multiple drugs and drug metabolites in urine at the following cut-off concentrations:
Test
Amphetamine (AMP1,000)
Amphetamine (AMP 500)
Amphetamine (AMP 300)
Barbiturates (BAR 300)
Barbiturates (BAR 200)
Benzodiazepines (BZO 500)
Benzodiazepines (BZO 300)
Benzodiazepines (BZO 200)
Benzodiazepines (BZO 100)
Buprenorphine (BUP)
Cocaine (COC 300)
Cocaine (COC 100)
Marijuana (THC150)
Marijuana (THC 50)
Marijuana (THC 25)
Methadone (MTD 300)
Methadone (MTD 200)
Methamphetamine (MET 1,000)
Methamphetamine (MET 500)
Methamphetamine (MET 300)
Methylenedioxymethamphetamine (MDMA 500)
Methylenedioxymethamphetamine (MDMA 1,000)
Morphine (MOP 300)
Morphine (MOP 100)
Methaqualone(MQL)
Opiate (OPI 2,000)
Phencyclidine (PCP)
Propoxyphene (PPX)
Tricyclic Antidepressants (TCA)
Tramadol (TML)
Ketamine (KET 1,000)
Ketamine (KET 500)
Ketamine (KET 300)
Ketamine (KET 100)
Oxycodone (OXY)
Cotinine(COT200)
Cotinine(COT100)
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP300)
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP100)
Fentanyl (FYL20)
Fentanyl (FYL10)
Synthetic Marijuana (K2-50)
Synthetic Marijuana (K2-30)
6-mono-aceto-morphine (6-MAM10)
(±) 3,4-Methylenedioxy- Amphetamine(MDA500)
Calibrator
Cut-off (ng/mL)
d-Amphetamine
d-Amphetamine
d-Amphetamine
Secobarbital
Secobarbital
Oxazepam
Oxazepam
Oxazepam
Oxazepam
Buprenorphine
Benzoylecgonine
Benzoylecgonine
11-nor-Δ9-THC-9 COOH
11-nor-Δ9-THC-9 COOH
11-nor-Δ9-THC-9 COOH
Methadone
Methadone
d-Methamphetamine
d-Methamphetamine
d-Methamphetamine
d,l-Methylenedioxymethamphetamine
d,l-Methylenedioxymethamphetamine
Morphine
Morphine
Methaqualone
Morphine
Phencyclidine
Propoxyphene
Nortriptyline
Cis-Tramadol
Ketamine
Ketamine
Ketamine
Ketamine
Oxycodone
Cotinine
Cotinine
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine
Norfentanyl
Norfentanyl
JWH-018、JWH-073
JWH-018、JWH-073
6-MAM
(±) 3,4-Methylenedioxy- Amphetamine
1000
500
300
300
200
500
300
200
100
10
300
100
150
50
25
300
200
1000
500
300
500
1000
300
100
300
2000
25
300
1000
100
1000
500
300
100
100
200
100
300
100
20
10
50
30
10
500
Configurations of The Multi-Drug Test Cassette come with any combination of the above listed drug analytes. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.
Multi 10 Drug Rapid Test
CE APPROVED
Cut off: 50 ng/ml
A rapid test for the qualitative detection of multiple drugs and drug metabolites in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The Multi-Drug Test Cassette/Dip card Panel is a rapid chromatographic immunoassay for the qualitative detection of multiple drugs and drug metabolites in urine at the following cut-off concentrations:
Test
Amphetamine (AMP1,000)
Amphetamine (AMP 500)
Amphetamine (AMP 300)
Barbiturates (BAR 300)
Barbiturates (BAR 200)
Benzodiazepines (BZO 500)
Benzodiazepines (BZO 300)
Benzodiazepines (BZO 200)
Benzodiazepines (BZO 100)
Buprenorphine (BUP)
Cocaine (COC 300)
Cocaine (COC 100)
Marijuana (THC150)
Marijuana (THC 50)
Marijuana (THC 25)
Methadone (MTD 300)
Methadone (MTD 200)
Methamphetamine (MET 1,000)
Methamphetamine (MET 500)
Methamphetamine (MET 300)
Methylenedioxymethamphetamine (MDMA 500)
Methylenedioxymethamphetamine (MDMA 1,000)
Morphine (MOP 300)
Morphine (MOP 100)
Methaqualone(MQL)
Opiate (OPI 2,000)
Phencyclidine (PCP)
Propoxyphene (PPX)
Tricyclic Antidepressants (TCA)
Tramadol (TML)
Ketamine (KET 1,000)
Ketamine (KET 500)
Ketamine (KET 300)
Ketamine (KET 100)
Oxycodone (OXY)
Cotinine(COT200)
Cotinine(COT100)
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP300)
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP100)
Fentanyl (FYL20)
Fentanyl (FYL10)
Synthetic Marijuana (K2-50)
Synthetic Marijuana (K2-30)
6-mono-aceto-morphine (6-MAM10)
(±) 3,4-Methylenedioxy- Amphetamine(MDA500)
Calibrator
Cut-off (ng/mL)
d-Amphetamine
d-Amphetamine
d-Amphetamine
Secobarbital
Secobarbital
Oxazepam
Oxazepam
Oxazepam
Oxazepam
Buprenorphine
Benzoylecgonine
Benzoylecgonine
11-nor-Δ9-THC-9 COOH
11-nor-Δ9-THC-9 COOH
11-nor-Δ9-THC-9 COOH
Methadone
Methadone
d-Methamphetamine
d-Methamphetamine
d-Methamphetamine
d,l-Methylenedioxymethamphetamine
d,l-Methylenedioxymethamphetamine
Morphine
Morphine
Methaqualone
Morphine
Phencyclidine
Propoxyphene
Nortriptyline
Cis-Tramadol
Ketamine
Ketamine
Ketamine
Ketamine
Oxycodone
Cotinine
Cotinine
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine
Norfentanyl
Norfentanyl
JWH-018、JWH-073
JWH-018、JWH-073
6-MAM
(±) 3,4-Methylenedioxy- Amphetamine
1000
500
300
300
200
500
300
200
100
10
300
100
150
50
25
300
200
1000
500
300
500
1000
300
100
300
2000
25
300
1000
100
1000
500
300
100
100
200
100
300
100
20
10
50
30
10
500
Configurations of The Multi-Drug Test Cassette come with any combination of the above listed drug analytes. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.
Multi 8 Drug Rapid Test
CE APPROVED
Cut off: 50 ng/ml
A rapid test for the qualitative detection of multiple drugs and drug metabolites in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The Multi-Drug Test Cassette/Dip card Panel is a rapid chromatographic immunoassay for the qualitative detection of multiple drugs and drug metabolites in urine at the following cut-off concentrations:
Test
Amphetamine (AMP1,000)
Amphetamine (AMP 500)
Amphetamine (AMP 300)
Barbiturates (BAR 300)
Barbiturates (BAR 200)
Benzodiazepines (BZO 500)
Benzodiazepines (BZO 300)
Benzodiazepines (BZO 200)
Benzodiazepines (BZO 100)
Buprenorphine (BUP)
Cocaine (COC 300)
Cocaine (COC 100)
Marijuana (THC150)
Marijuana (THC 50)
Marijuana (THC 25)
Methadone (MTD 300)
Methadone (MTD 200)
Methamphetamine (MET 1,000)
Methamphetamine (MET 500)
Methamphetamine (MET 300)
Methylenedioxymethamphetamine (MDMA 500)
Methylenedioxymethamphetamine (MDMA 1,000)
Morphine (MOP 300)
Morphine (MOP 100)
Methaqualone(MQL)
Opiate (OPI 2,000)
Phencyclidine (PCP)
Propoxyphene (PPX)
Tricyclic Antidepressants (TCA)
Tramadol (TML)
Ketamine (KET 1,000)
Ketamine (KET 500)
Ketamine (KET 300)
Ketamine (KET 100)
Oxycodone (OXY)
Cotinine(COT200)
Cotinine(COT100)
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP300)
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP100)
Fentanyl (FYL20)
Fentanyl (FYL10)
Synthetic Marijuana (K2-50)
Synthetic Marijuana (K2-30)
6-mono-aceto-morphine (6-MAM10)
(±) 3,4-Methylenedioxy- Amphetamine(MDA500)
Calibrator
Cut-off (ng/mL)
d-Amphetamine
d-Amphetamine
d-Amphetamine
Secobarbital
Secobarbital
Oxazepam
Oxazepam
Oxazepam
Oxazepam
Buprenorphine
Benzoylecgonine
Benzoylecgonine
11-nor-Δ9-THC-9 COOH
11-nor-Δ9-THC-9 COOH
11-nor-Δ9-THC-9 COOH
Methadone
Methadone
d-Methamphetamine
d-Methamphetamine
d-Methamphetamine
d,l-Methylenedioxymethamphetamine
d,l-Methylenedioxymethamphetamine
Morphine
Morphine
Methaqualone
Morphine
Phencyclidine
Propoxyphene
Nortriptyline
Cis-Tramadol
Ketamine
Ketamine
Ketamine
Ketamine
Oxycodone
Cotinine
Cotinine
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine
Norfentanyl
Norfentanyl
JWH-018、JWH-073
JWH-018、JWH-073
6-MAM
(±) 3,4-Methylenedioxy- Amphetamine
1000
500
300
300
200
500
300
200
100
10
300
100
150
50
25
300
200
1000
500
300
500
1000
300
100
300
2000
25
300
1000
100
1000
500
300
100
100
200
100
300
100
20
10
50
30
10
500
Configurations of The Multi-Drug Test Cassette come with any combination of the above listed drug analytes. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.
Multi 6 Drug Rapid Test
CE APPROVED
Cut off: 50 ng/ml
A rapid test for the qualitative detection of multiple drugs and drug metabolites in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The Multi-Drug Test Cassette/Dip card Panel is a rapid chromatographic immunoassay for the qualitative detection of multiple drugs and drug metabolites in urine at the following cut-off concentrations:
Test
Amphetamine (AMP1,000)
Amphetamine (AMP 500)
Amphetamine (AMP 300)
Barbiturates (BAR 300)
Barbiturates (BAR 200)
Benzodiazepines (BZO 500)
Benzodiazepines (BZO 300)
Benzodiazepines (BZO 200)
Benzodiazepines (BZO 100)
Buprenorphine (BUP)
Cocaine (COC 300)
Cocaine (COC 100)
Marijuana (THC150)
Marijuana (THC 50)
Marijuana (THC 25)
Methadone (MTD 300)
Methadone (MTD 200)
Methamphetamine (MET 1,000)
Methamphetamine (MET 500)
Methamphetamine (MET 300)
Methylenedioxymethamphetamine (MDMA 500)
Methylenedioxymethamphetamine (MDMA 1,000)
Morphine (MOP 300)
Morphine (MOP 100)
Methaqualone(MQL)
Opiate (OPI 2,000)
Phencyclidine (PCP)
Propoxyphene (PPX)
Tricyclic Antidepressants (TCA)
Tramadol (TML)
Ketamine (KET 1,000)
Ketamine (KET 500)
Ketamine (KET 300)
Ketamine (KET 100)
Oxycodone (OXY)
Cotinine(COT200)
Cotinine(COT100)
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP300)
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP100)
Fentanyl (FYL20)
Fentanyl (FYL10)
Synthetic Marijuana (K2-50)
Synthetic Marijuana (K2-30)
6-mono-aceto-morphine (6-MAM10)
(±) 3,4-Methylenedioxy- Amphetamine(MDA500)
Calibrator
Cut-off (ng/mL)
d-Amphetamine
d-Amphetamine
d-Amphetamine
Secobarbital
Secobarbital
Oxazepam
Oxazepam
Oxazepam
Oxazepam
Buprenorphine
Benzoylecgonine
Benzoylecgonine
11-nor-Δ9-THC-9 COOH
11-nor-Δ9-THC-9 COOH
11-nor-Δ9-THC-9 COOH
Methadone
Methadone
d-Methamphetamine
d-Methamphetamine
d-Methamphetamine
d,l-Methylenedioxymethamphetamine
d,l-Methylenedioxymethamphetamine
Morphine
Morphine
Methaqualone
Morphine
Phencyclidine
Propoxyphene
Nortriptyline
Cis-Tramadol
Ketamine
Ketamine
Ketamine
Ketamine
Oxycodone
Cotinine
Cotinine
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine
Norfentanyl
Norfentanyl
JWH-018、JWH-073
JWH-018、JWH-073
6-MAM
(±) 3,4-Methylenedioxy- Amphetamine
1000
500
300
300
200
500
300
200
100
10
300
100
150
50
25
300
200
1000
500
300
500
1000
300
100
300
2000
25
300
1000
100
1000
500
300
100
100
200
100
300
100
20
10
50
30
10
500
Configurations of The Multi-Drug Test Cassette come with any combination of the above listed drug analytes. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.
Multi 5 Drug Rapid Test
CE APPROVED
Cut off: 50 ng/ml
A rapid test for the qualitative detection of multiple drugs and drug metabolites in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The Multi-Drug Test Cassette/Dip card Panel is a rapid chromatographic immunoassay for the qualitative detection of multiple drugs and drug metabolites in urine at the following cut-off concentrations:
Test
Amphetamine (AMP1,000)
Amphetamine (AMP 500)
Amphetamine (AMP 300)
Barbiturates (BAR 300)
Barbiturates (BAR 200)
Benzodiazepines (BZO 500)
Benzodiazepines (BZO 300)
Benzodiazepines (BZO 200)
Benzodiazepines (BZO 100)
Buprenorphine (BUP)
Cocaine (COC 300)
Cocaine (COC 100)
Marijuana (THC150)
Marijuana (THC 50)
Marijuana (THC 25)
Methadone (MTD 300)
Methadone (MTD 200)
Methamphetamine (MET 1,000)
Methamphetamine (MET 500)
Methamphetamine (MET 300)
Methylenedioxymethamphetamine (MDMA 500)
Methylenedioxymethamphetamine (MDMA 1,000)
Morphine (MOP 300)
Morphine (MOP 100)
Methaqualone(MQL)
Opiate (OPI 2,000)
Phencyclidine (PCP)
Propoxyphene (PPX)
Tricyclic Antidepressants (TCA)
Tramadol (TML)
Ketamine (KET 1,000)
Ketamine (KET 500)
Ketamine (KET 300)
Ketamine (KET 100)
Oxycodone (OXY)
Cotinine(COT200)
Cotinine(COT100)
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP300)
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP100)
Fentanyl (FYL20)
Fentanyl (FYL10)
Synthetic Marijuana (K2-50)
Synthetic Marijuana (K2-30)
6-mono-aceto-morphine (6-MAM10)
(±) 3,4-Methylenedioxy- Amphetamine(MDA500)
Calibrator
Cut-off (ng/mL)
d-Amphetamine
d-Amphetamine
d-Amphetamine
Secobarbital
Secobarbital
Oxazepam
Oxazepam
Oxazepam
Oxazepam
Buprenorphine
Benzoylecgonine
Benzoylecgonine
11-nor-Δ9-THC-9 COOH
11-nor-Δ9-THC-9 COOH
11-nor-Δ9-THC-9 COOH
Methadone
Methadone
d-Methamphetamine
d-Methamphetamine
d-Methamphetamine
d,l-Methylenedioxymethamphetamine
d,l-Methylenedioxymethamphetamine
Morphine
Morphine
Methaqualone
Morphine
Phencyclidine
Propoxyphene
Nortriptyline
Cis-Tramadol
Ketamine
Ketamine
Ketamine
Ketamine
Oxycodone
Cotinine
Cotinine
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine
Norfentanyl
Norfentanyl
JWH-018、JWH-073
JWH-018、JWH-073
6-MAM
(±) 3,4-Methylenedioxy- Amphetamine
1000
500
300
300
200
500
300
200
100
10
300
100
150
50
25
300
200
1000
500
300
500
1000
300
100
300
2000
25
300
1000
100
1000
500
300
100
100
200
100
300
100
20
10
50
30
10
500
Configurations of The Multi-Drug Test Cassette come with any combination of the above listed drug analytes. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.
Multi 3 Drug Rapid Test
CE APPROVED
Cut off: 50 ng/ml
A rapid test for the qualitative detection of multiple drugs and drug metabolites in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The Multi-Drug Test Cassette/Dip card Panel is a rapid chromatographic immunoassay for the qualitative detection of multiple drugs and drug metabolites in urine at the following cut-off concentrations:
Test
Amphetamine (AMP1,000)
Amphetamine (AMP 500)
Amphetamine (AMP 300)
Barbiturates (BAR 300)
Barbiturates (BAR 200)
Benzodiazepines (BZO 500)
Benzodiazepines (BZO 300)
Benzodiazepines (BZO 200)
Benzodiazepines (BZO 100)
Buprenorphine (BUP)
Cocaine (COC 300)
Cocaine (COC 100)
Marijuana (THC150)
Marijuana (THC 50)
Marijuana (THC 25)
Methadone (MTD 300)
Methadone (MTD 200)
Methamphetamine (MET 1,000)
Methamphetamine (MET 500)
Methamphetamine (MET 300)
Methylenedioxymethamphetamine (MDMA 500)
Methylenedioxymethamphetamine (MDMA 1,000)
Morphine (MOP 300)
Morphine (MOP 100)
Methaqualone(MQL)
Opiate (OPI 2,000)
Phencyclidine (PCP)
Propoxyphene (PPX)
Tricyclic Antidepressants (TCA)
Tramadol (TML)
Ketamine (KET 1,000)
Ketamine (KET 500)
Ketamine (KET 300)
Ketamine (KET 100)
Oxycodone (OXY)
Cotinine(COT200)
Cotinine(COT100)
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP300)
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP100)
Fentanyl (FYL20)
Fentanyl (FYL10)
Synthetic Marijuana (K2-50)
Synthetic Marijuana (K2-30)
6-mono-aceto-morphine (6-MAM10)
(±) 3,4-Methylenedioxy- Amphetamine(MDA500)
Calibrator
Cut-off (ng/mL)
d-Amphetamine
d-Amphetamine
d-Amphetamine
Secobarbital
Secobarbital
Oxazepam
Oxazepam
Oxazepam
Oxazepam
Buprenorphine
Benzoylecgonine
Benzoylecgonine
11-nor-Δ9-THC-9 COOH
11-nor-Δ9-THC-9 COOH
11-nor-Δ9-THC-9 COOH
Methadone
Methadone
d-Methamphetamine
d-Methamphetamine
d-Methamphetamine
d,l-Methylenedioxymethamphetamine
d,l-Methylenedioxymethamphetamine
Morphine
Morphine
Methaqualone
Morphine
Phencyclidine
Propoxyphene
Nortriptyline
Cis-Tramadol
Ketamine
Ketamine
Ketamine
Ketamine
Oxycodone
Cotinine
Cotinine
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine
Norfentanyl
Norfentanyl
JWH-018、JWH-073
JWH-018、JWH-073
6-MAM
(±) 3,4-Methylenedioxy- Amphetamine
1000
500
300
300
200
500
300
200
100
10
300
100
150
50
25
300
200
1000
500
300
500
1000
300
100
300
2000
25
300
1000
100
1000
500
300
100
100
200
100
300
100
20
10
50
30
10
500
Configurations of The Multi-Drug Test Cassette come with any combination of the above listed drug analytes. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.
Multi 2 Drug Rapid Test
CE APPROVED
Cut off: 50 ng/ml
A rapid test for the qualitative detection of multiple drugs and drug metabolites in human urine. For laboratory in vitro diagnostic use only.
Intended Use:
The Multi-Drug Test Cassette/Dip card Panel is a rapid chromatographic immunoassay for the qualitative detection of multiple drugs and drug metabolites in urine at the following cut-off concentrations:
Test
Amphetamine (AMP1,000)
Amphetamine (AMP 500)
Amphetamine (AMP 300)
Barbiturates (BAR 300)
Barbiturates (BAR 200)
Benzodiazepines (BZO 500)
Benzodiazepines (BZO 300)
Benzodiazepines (BZO 200)
Benzodiazepines (BZO 100)
Buprenorphine (BUP)
Cocaine (COC 300)
Cocaine (COC 100)
Marijuana (THC150)
Marijuana (THC 50)
Marijuana (THC 25)
Methadone (MTD 300)
Methadone (MTD 200)
Methamphetamine (MET 1,000)
Methamphetamine (MET 500)
Methamphetamine (MET 300)
Methylenedioxymethamphetamine (MDMA 500)
Methylenedioxymethamphetamine (MDMA 1,000)
Morphine (MOP 300)
Morphine (MOP 100)
Methaqualone(MQL)
Opiate (OPI 2,000)
Phencyclidine (PCP)
Propoxyphene (PPX)
Tricyclic Antidepressants (TCA)
Tramadol (TML)
Ketamine (KET 1,000)
Ketamine (KET 500)
Ketamine (KET 300)
Ketamine (KET 100)
Oxycodone (OXY)
Cotinine(COT200)
Cotinine(COT100)
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP300)
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP100)
Fentanyl (FYL20)
Fentanyl (FYL10)
Synthetic Marijuana (K2-50)
Synthetic Marijuana (K2-30)
6-mono-aceto-morphine (6-MAM10)
(±) 3,4-Methylenedioxy- Amphetamine(MDA500)
Calibrator
Cut-off (ng/mL)
d-Amphetamine
d-Amphetamine
d-Amphetamine
Secobarbital
Secobarbital
Oxazepam
Oxazepam
Oxazepam
Oxazepam
Buprenorphine
Benzoylecgonine
Benzoylecgonine
11-nor-Δ9-THC-9 COOH
11-nor-Δ9-THC-9 COOH
11-nor-Δ9-THC-9 COOH
Methadone
Methadone
d-Methamphetamine
d-Methamphetamine
d-Methamphetamine
d,l-Methylenedioxymethamphetamine
d,l-Methylenedioxymethamphetamine
Morphine
Morphine
Methaqualone
Morphine
Phencyclidine
Propoxyphene
Nortriptyline
Cis-Tramadol
Ketamine
Ketamine
Ketamine
Ketamine
Oxycodone
Cotinine
Cotinine
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine
2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine
Norfentanyl
Norfentanyl
JWH-018、JWH-073
JWH-018、JWH-073
6-MAM
(±) 3,4-Methylenedioxy- Amphetamine
1000
500
300
300
200
500
300
200
100
10
300
100
150
50
25
300
200
1000
500
300
500
1000
300
100
300
2000
25
300
1000
100
1000
500
300
100
100
200
100
300
100
20
10
50
30
10
500
Configurations of The Multi-Drug Test Cassette come with any combination of the above listed drug analytes. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.